Itacitinib (INCB039110) is an oral selective JAK1 inhibitor.
Itacitinib is an inhibitor of the Janus kinases (JAKs) with selectivity for JAK1. Itacitinib potently inhibits OCT2-mediated uptake of creatinine as well as MATE1-/MATE2-K-mediated efflux of creatinine. Itacitinib causes a dose-dependent decrease in transcellular transport of creatinine with weaker net inhibition compared with the effects on individual transporters.
For research use only. We do not sell to patients.
Name | Itacitinib |
---|---|
Iupac Chemical Name | Itacitinib |
Synonyms | INCB039110; INCB-039110; INCB 039110 |
Molecular Formula | C26H23F4N9O |
Molecular Weight | 553.51 |
InChiKey | |
InChi | |
CAS Number | 1334298-90-6 |
Related CAS |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | crystalline solid |
---|---|
Purity | 98% |
Storage | 3 years -20ºCpowder |
Solubility | Soluble in DMSO |
Handling | |
Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. |
HS Code |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |